Also known as: Trimeproprimine; Piroheptinum
Piroheptine is an anticholinergic agent used in the treatment of Parkinson's disease and drug-induced extrapyramidal symptoms. It acts as a central muscarinic receptor antagonist, reducing the relative excess of cholinergic activity in the basal ganglia. Mediocon Inc manufactures Piroheptine API at its GMP-certified facility in Aurangabad, Maharashtra, India.
| Parameter | Specification |
|---|---|
| CAS Number | 113-27-1 |
| Molecular Formula | C21H27N |
| Molecular Weight | 293.45 g/mol |
| Grade | IP / BP / USP |
| Category | Antiparkinson Agent / Anticholinergic |
| Appearance | White to off-white, crystalline powder |
| Solubility | Freely soluble in water, sparingly soluble in ethanol, practically insoluble in ether |
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Batch No | PIR/24032026 |
| Mfg Date | MAR 2026 |
| Exp Date | FEB 2031 |
| Packing | 25 kg HDPE drums / as per requirement |